Zymes Tech Private Limited - Company Profile

It is a pharma private limited company based in New Delhi, Delhi, India, established in 2020.
2020 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Zymes Tech Private Limited

Zymes Tech Private Limited, a active private limited company, was established on 06 August 2020 in New Delhi, Delhi, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U33302DL2020PTC367528. Registered under ROC Roc Delhi I. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Chandan Chopra (Director), Aniket Dhingra (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at B-20, 02Nd Floor, Okhla Industrial Area Phase-1,, New Delhi, Delhi, 110020.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33302DL2020PTC367528

  • Registration Number

    367528

  • Incorporation Date

    06 August 2020

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 5 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Zymes Tech Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Zymes Tech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Zymes Tech Private Limited?
Current Directors
Name Designation Appointment Date Status
Chandan Chopra Director 06 Aug 2020 Current
Aniket Dhingra Director 06 Aug 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Zymes Tech.

Enhance accessibility to Zymes Tech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Zymes Tech revenue growth over time
Zymes Tech profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Zymes Tech?

Unlock access to Zymes Tech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Zymes Tech?

Zymes Tech has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Zymes Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zymes Tech's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Zymes Tech
Recent Activity within the Organization
  • Annual General Meeting

    Zymes Tech Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Zymes Tech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I. was completed.

  • Director Appointment

    Progress on Chandan Chopra was appointed as a Director was appointed as a Director on 06 Aug 2020 & has been associated with this company since 5 years 6 months . was documented.

  • Director Appointment

    Progress on Aniket Dhingra was appointed as a Director was appointed as a Director on 06 Aug 2020 & has been associated with this company since 5 years 6 months . was documented.

  • Company Incorporation

    The activity Zymes Tech Private Limited was registered on 06 Aug 2020 with Roc Delhi I & aged 5 years 6 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Zymes Tech Private Limited?

The CIN of Zymes Tech Private Limited is U33302DL2020PTC367528.

Where is Zymes Tech Private Limited headquartered?

Zymes Tech Private Limited is headquartered at B-20, 02Nd Floor, Okhla Industrial Area Phase-1,, New Delhi, Delhi, 110020.

When was Zymes Tech Private Limited incorporated?

Zymes Tech Private Limited was incorporated on 06 August 2020.

Who are the current directors of Zymes Tech Private Limited?

The current directors of Zymes Tech Private Limited are

What is the primary industry of Zymes Tech Private Limited?

The primary industry of Zymes Tech Private Limited is Pharma.

Is Zymes Tech Private Limited a listed company?

Zymes Tech Private Limited is unlisted.

What is the capital structure of Zymes Tech Private Limited?

The authorized capital of Zymes Tech Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available